<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): AUGUST 22, 1997
---------------
PERSEPTIVE BIOSYSTEMS, INC.
______________________________________________________
(Exact name of registrant as specified in its charter)
DELAWARE
______________________________________________
(State or other jurisdiction of incorporation)
0-20032 04-2987616
________________________ ______________________
(Commission File Number) (IRS Employer Id. No.)
500 Old Connecticut Path Framingham, MA 01701
_____________________________________________________
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(508) 383-7700
______________
<PAGE>
ITEM 5. OTHER EVENTS.
------------
On August 22, 1997 the Company issued 1,019,108 shares of its common stock,
$.01 par value per share, to Millipore Corporation in payment of the third $10
million installment due upon the redemption by Millipore Corporation of 1,000
shares of the Company's non-voting Series A Redeemable Convertible Preferred
Stock, $.01 par value per share (the "Redeemable Preferred Stock"). The
Redeemable Preferred Stock was issued to Millipore Corporation in connection
with the acquisition of the BioSearch division of Millipore Corporation in
August 1994. Pursuant to the terms of the acquisition, the Company has
registered such shares for resale by Millipore Corporation.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
---------------------------------
(c) Exhibits.
--------
None.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PERSEPTIVE BIOSYSTEMS, INC.
By: /s/ Noubar B. Afeyan
-------------------------------
Noubar B. Afeyan, Chairman and
Chief Executive Officer
Dated: August 26, 1997
-3-
